Genesis Healthcare, Inc.
Genesis Healthcare, Inc. (GENN) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
genn · stock forecast · 13 analysts (3M) · FMP
Analyst Rating & Consensus
Based on 13 Wall Street analysts in the past 3 months
Buy
13 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.00
Short-Term Price Prediction
Short-term price predictions will be available once the prediction engine is ready.
Long-Term Stock Price Prediction
Long-term price predictions will be available once the prediction engine is ready.
Stock Forecast Based on Technical Analysis
Technical analysis will be available once the prediction engine is ready.
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|
Wall Street analysts have recently issued updated ratings on Genesis Healthcare, Inc. (GENN) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 13 analysts currently cover GENN.
Analyst Recommendation Trends
GENN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast GENN EPS of $— for the current fiscal year, based on estimates from 0 analysts. The GENN revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The GENN stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus GENN price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
Genesis Healthcare, Inc. trades on OTC under the ticker GENN. The GENN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 38% of covering analysts.
Frequently asked questions
GENN forecast · 8 questionsAccording to 13 Wall Street analysts, the average 12-month GENN price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $0.00.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.